[1] 范建高,贾继东. 脂肪性肝病诊疗进展[M]. 北京:人民卫生出版社,2009:79-87.
[2] FAN JG,FARRELL GC. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol,2009,50（1）：204-210.
[3] VUPPALANCHI R,CHALASANI N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis：selected practical issues in their evaluation and management[J]. Hepatology,2009,49（2）：306-317.
[4] 王炳元,范建高. 第3届全国脂肪性肝病学术会议暨两岸三地高峰论坛纪要[J]. 实用肝脏病杂志,2009,12（6）：402-403.
[5] 范建高. 重视慢性病毒性肝炎合并脂肪肝的诊断与治疗[J]. 中华肝脏病杂志,2009,17（11）：801-803.
[6] 段晓燕,范建高. 代谢性危险因素与病毒性肝炎[J]. 实用肝脏病杂志,2009,12（6）：462-467.
[7] ALI R,CUSI K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease（NAFLD）[J]. Ann Med,2009,41（2）：265-278.
[8] 范建高. 糖尿病与肝病的关系及其诊治对策[J]. 中华糖尿病杂志,2009,1（4）：244-247.
[9] FAN JG,FARRELL GC. Prevention of hepatocellular carcinoma in non-viral related liver diseases[J]. J Gastroenterol Hepatol,2009,24（5）：712-719.
[10] LOOMBA R,SIRLIN CB,SCHWIMMER JB,et al. Advances in pediatric nonalcoholic fatty liver disease[J]. Hepatology,2009,50（4）：1282-1293.
[11] RILEY P,AL BAKIR M,O'DONOHUE J,et al. Prescribing statins to patients with nonalcoholic fatty liver disease：real cardiovascular benefits outweigh theoretical hepatotoxic risk[J]. Cardiovasc Ther,2009,27（2）：216-220. |
